Plew Daniel P Van Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Plew Daniel P Van.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Plew Daniel P Van. Plew Daniel P Van is EVP & General Mgr Industrial O in REGENERON PHARMACEUTICALS INC ($REGN) and SVP & Gen Mgr IOPS in REGENERON PHARMACEUTICALS INC ($REGN) and SVP & General Mgr Industrial O in REGENERON PHARMACEUTICALS INC ($REGN) and SVP & GM, Ind Ops & Prod Supp in REGENERON PHARMACEUTICALS INC ($REGN) and SVP & GM, Indust Ops&Prod Supp in REGENERON PHARMACEUTICALS INC ($REGN) and VP & Gn Mgr Ind Ops & Prod Sup in REGENERON PHARMACEUTICALS INC ($REGN).
Latest Insider Trading Transactions of Plew Daniel P Van
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | A | 492.00 | 19,950 | 9,815,400 | 19,950 | |
| Dec 11 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Grant | A | 0.00 | 5,000 | 0 | 26,931 | 21.9 K to 26.9 K (+22.80 %) |
| Dec 11 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Grant | A | 0.00 | 1,930 | 0 | 21,931 | 20 K to 21.9 K (+9.65 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 614.24 | 1,288 | 791,141 | 20,001 | 21.3 K to 20 K (-6.05 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 613.62 | 1,560 | 957,247 | 21,289 | 22.8 K to 21.3 K (-6.83 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 612.49 | 4,044 | 2,476,910 | 22,849 | 26.9 K to 22.8 K (-15.04 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 611.40 | 1,980 | 1,210,572 | 26,893 | 28.9 K to 26.9 K (-6.86 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 610.41 | 7,981 | 4,871,682 | 28,873 | 36.9 K to 28.9 K (-21.66 %) |
| Aug 27 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 609.71 | 10,256 | 6,253,186 | 36,854 | 47.1 K to 36.9 K (-21.77 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 179.13 | 75,000 | 13,434,750 | 0 | |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Payment of Exercise | F | 614.09 | 47,891 | 29,409,384 | 47,110 | 95 K to 47.1 K (-50.41 %) |
| Aug 24 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Buy | M | 179.13 | 75,000 | 13,434,750 | 95,001 | 20 K to 95 K (+374.98 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 52.03 | 52,500 | 2,731,575 | 0 | |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 52.03 | 33,079 | 1,721,100 | 52,500 | |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 569.42 | 700 | 398,594 | 28,251 | 29 K to 28.3 K (-2.42 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 568.57 | 3,040 | 1,728,453 | 28,951 | 32 K to 29 K (-9.50 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 567.35 | 3,753 | 2,129,265 | 31,991 | 35.7 K to 32 K (-10.50 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 566.47 | 7,297 | 4,133,532 | 35,744 | 43 K to 35.7 K (-16.95 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 565.49 | 5,984 | 3,383,892 | 43,041 | 49 K to 43 K (-12.21 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 564.54 | 3,000 | 1,693,620 | 49,025 | 52 K to 49 K (-5.77 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 563.58 | 2,195 | 1,237,058 | 52,025 | 54.2 K to 52 K (-4.05 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 562.45 | 2,077 | 1,168,209 | 54,220 | 56.3 K to 54.2 K (-3.69 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 561.55 | 4,988 | 2,801,011 | 56,297 | 61.3 K to 56.3 K (-8.14 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 560.53 | 3,231 | 1,811,072 | 61,285 | 64.5 K to 61.3 K (-5.01 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 559.20 | 500 | 279,600 | 64,516 | 65 K to 64.5 K (-0.77 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 558.43 | 2,118 | 1,182,755 | 65,016 | 67.1 K to 65 K (-3.15 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 557.59 | 600 | 334,554 | 67,134 | 67.7 K to 67.1 K (-0.89 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 556.92 | 100 | 55,692 | 67,734 | 67.8 K to 67.7 K (-0.15 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Payment of Exercise | F | 555.77 | 28,217 | 15,682,162 | 67,834 | 96.1 K to 67.8 K (-29.38 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Buy | M | 52.03 | 52,500 | 2,731,575 | 96,051 | 43.6 K to 96.1 K (+120.55 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Payment of Exercise | F | 555.77 | 17,779 | 9,881,035 | 43,551 | 61.3 K to 43.6 K (-28.99 %) |
| May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Buy | M | 52.03 | 33,079 | 1,721,100 | 61,330 | 28.3 K to 61.3 K (+117.09 %) |
| Dec 13 2019 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
| Dec 13 2019 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Grant | A | 0.00 | 5,000 | 0 | 28,251 | 23.3 K to 28.3 K (+21.50 %) |
| Dec 13 2019 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Grant | A | 0.00 | 2,625 | 0 | 23,251 | 20.6 K to 23.3 K (+12.73 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | A | 381.40 | 46,250 | 17,639,750 | 46,250 | |
| Dec 13 2017 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | A | 378.98 | 50,000 | 18,949,000 | 50,000 | |
| Dec 19 2016 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | A | 381.92 | 34,000 | 12,985,280 | 34,000 | |
| May 19 2016 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 30.63 | 9,460 | 289,760 | 32,735 | |
| May 19 2016 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 385.77 | 4,413 | 1,702,403 | 1,921 | 6.3 K to 1.9 K (-69.67 %) |
| May 19 2016 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Payment of Exercise | F | 388.14 | 4,301 | 1,669,390 | 6,334 | 10.6 K to 6.3 K (-40.44 %) |
| May 19 2016 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Payment of Exercise | F | 388.14 | 746 | 289,552 | 10,635 | 11.4 K to 10.6 K (-6.55 %) |
| May 19 2016 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Buy | M | 30.63 | 9,460 | 289,760 | 11,381 | 1.9 K to 11.4 K (+492.45 %) |
| Dec 18 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | A | 555.67 | 40,000 | 22,226,800 | 40,000 | |
| Dec 18 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
| Dec 18 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 52.03 | 1,921 | 99,950 | 1,921 | 0 to 1.9 K |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 5,486 | 168,036 | 42,195 | |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 5,700 | 174,591 | 47,681 | |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 557.14 | 1,223 | 681,382 | 0 | 1.2 K to 0 (-100.00 %) |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 556.00 | 1,000 | 556,000 | 1,223 | 2.2 K to 1.2 K (-44.98 %) |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 554.39 | 2,000 | 1,108,780 | 2,223 | 4.2 K to 2.2 K (-47.36 %) |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 552.50 | 50 | 27,625 | 4,223 | 4.3 K to 4.2 K (-1.17 %) |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 551.45 | 850 | 468,733 | 4,273 | 5.1 K to 4.3 K (-16.59 %) |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 2,674 | 1,496,076 | 5,123 | 7.8 K to 5.1 K (-34.30 %) |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 300 | 167,847 | 7,797 | 8.1 K to 7.8 K (-3.71 %) |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 5,486 | 168,036 | 8,097 | 2.6 K to 8.1 K (+210.11 %) |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 2,778 | 1,554,263 | 2,611 | 5.4 K to 2.6 K (-51.55 %) |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 311 | 174,001 | 5,389 | 5.7 K to 5.4 K (-5.46 %) |
| Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 5,700 | 174,591 | 5,700 | 0 to 5.7 K |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 4,605 | 141,051 | 53,381 | |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 4,095 | 87,019 | 0 | |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 586.24 | 1,128 | 661,279 | 0 | 1.1 K to 0 (-100.00 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 585.02 | 900 | 526,518 | 1,128 | 2 K to 1.1 K (-44.38 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 583.89 | 1,000 | 583,890 | 2,028 | 3 K to 2 K (-33.03 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 582.12 | 1,000 | 582,120 | 3,028 | 4 K to 3 K (-24.83 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 588.64 | 2,035 | 1,197,882 | 4,028 | 6.1 K to 4 K (-33.56 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 588.64 | 147 | 86,530 | 6,063 | 6.2 K to 6.1 K (-2.37 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 4,095 | 87,019 | 6,210 | 2.1 K to 6.2 K (+193.62 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 588.64 | 2,251 | 1,325,029 | 2,115 | 4.4 K to 2.1 K (-51.56 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 588.64 | 239 | 140,685 | 4,366 | 4.6 K to 4.4 K (-5.19 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 4,605 | 141,051 | 4,605 | 0 to 4.6 K |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 26,250 | 804,038 | 57,986 | |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 13,800 | 293,250 | 4,095 | |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 510.02 | 99 | 50,492 | 0 | 99 to 0 (-100.00 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 509.34 | 7,506 | 3,823,106 | 99 | 7.6 K to 99 (-98.70 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 508.53 | 3,886 | 1,976,148 | 7,605 | 11.5 K to 7.6 K (-33.82 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 507.34 | 6,879 | 3,489,992 | 11,491 | 18.4 K to 11.5 K (-37.45 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 516.48 | 6,823 | 3,523,943 | 18,370 | 25.2 K to 18.4 K (-27.08 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 516.48 | 567 | 292,844 | 25,193 | 25.8 K to 25.2 K (-2.20 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 13,800 | 293,250 | 25,760 | 12 K to 25.8 K (+115.38 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 516.48 | 12,734 | 6,576,856 | 11,960 | 24.7 K to 12 K (-51.57 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 516.48 | 1,556 | 803,643 | 24,694 | 26.3 K to 24.7 K (-5.93 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 26,250 | 804,038 | 26,250 | 0 to 26.3 K |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 20,000 | 425,000 | 17,895 | |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 429.09 | 3,331 | 1,429,299 | 18,705 | 22 K to 18.7 K (-15.12 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 428.27 | 2,100 | 899,367 | 22,036 | 24.1 K to 22 K (-8.70 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 427.12 | 1,700 | 726,104 | 24,136 | 25.8 K to 24.1 K (-6.58 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 426.08 | 2,300 | 979,984 | 25,836 | 28.1 K to 25.8 K (-8.17 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 424.70 | 9,569 | 4,063,954 | 28,136 | 37.7 K to 28.1 K (-25.38 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 424.70 | 1,000 | 424,700 | 37,705 | 38.7 K to 37.7 K (-2.58 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 20,000 | 425,000 | 38,705 | 18.7 K to 38.7 K (+106.92 %) |
| Dec 19 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 3,264 | 99,976 | 0 | |
| Dec 19 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 3,264 | 99,976 | 18,705 | 15.4 K to 18.7 K (+21.14 %) |
| Dec 18 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | A | 399.66 | 40,000 | 15,986,400 | 40,000 | |
| Dec 18 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | A | 52.03 | 52,500 | 2,731,575 | 85,579 | |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 18,700 | 397,375 | 37,895 | |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 399.95 | 1,501 | 600,325 | 15,441 | 16.9 K to 15.4 K (-8.86 %) |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 399.21 | 7,074 | 2,824,012 | 16,942 | 24 K to 16.9 K (-29.46 %) |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 398.93 | 9,129 | 3,641,832 | 24,016 | 33.1 K to 24 K (-27.54 %) |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 398.93 | 996 | 397,334 | 33,145 | 34.1 K to 33.1 K (-2.92 %) |
| Nov 14 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 18,700 | 397,375 | 34,141 | 15.4 K to 34.1 K (+121.11 %) |
| Aug 07 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 15,000 | 318,750 | 56,595 | |
| Aug 07 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 338.37 | 6,806 | 2,302,946 | 15,441 | 22.2 K to 15.4 K (-30.59 %) |
| Aug 07 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 336.11 | 7,246 | 2,435,453 | 22,247 | 29.5 K to 22.2 K (-24.57 %) |
| Aug 07 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 336.11 | 948 | 318,632 | 29,493 | 30.4 K to 29.5 K (-3.11 %) |
| Aug 07 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 15,000 | 318,750 | 30,441 | 15.4 K to 30.4 K (+97.14 %) |
| May 23 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 11,200 | 238,000 | 71,595 | |
| May 23 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 296.70 | 2,369 | 702,882 | 15,441 | 17.8 K to 15.4 K (-13.30 %) |
| May 23 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 295.33 | 3,000 | 885,990 | 17,810 | 20.8 K to 17.8 K (-14.42 %) |
| May 23 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 296.19 | 5,028 | 1,489,243 | 20,810 | 25.8 K to 20.8 K (-19.46 %) |
| May 23 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 296.19 | 803 | 237,841 | 25,838 | 26.6 K to 25.8 K (-3.01 %) |
| May 23 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 11,200 | 238,000 | 26,641 | 15.4 K to 26.6 K (+72.53 %) |
| Dec 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 4,705 | 99,981 | 0 | |
| Dec 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 4,705 | 99,981 | 15,441 | 10.7 K to 15.4 K (+43.82 %) |
| Dec 17 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | A | 270.43 | 50,000 | 13,521,500 | 50,000 | |
| Dec 17 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | A | 30.63 | 52,500 | 1,608,075 | 84,236 | |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Option Exercise | M | 16.80 | 52,500 | 882,000 | 0 | |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Sell | S | 308.26 | 1,000 | 308,260 | 10,736 | 11.7 K to 10.7 K (-8.52 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Sell | S | 307.28 | 3,200 | 983,296 | 11,736 | 14.9 K to 11.7 K (-21.42 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Sell | S | 306.40 | 3,600 | 1,103,040 | 14,936 | 18.5 K to 14.9 K (-19.42 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Sell | S | 305.14 | 3,556 | 1,085,078 | 18,536 | 22.1 K to 18.5 K (-16.10 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Sell | S | 304.16 | 1,444 | 439,207 | 22,092 | 23.5 K to 22.1 K (-6.14 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Sell | S | 303.01 | 600 | 181,806 | 23,536 | 24.1 K to 23.5 K (-2.49 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Sell | S | 301.42 | 1,400 | 421,988 | 24,136 | 25.5 K to 24.1 K (-5.48 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Sell | S | 300.62 | 2,600 | 781,612 | 25,536 | 28.1 K to 25.5 K (-9.24 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Sell | S | 299.34 | 2,800 | 838,152 | 28,136 | 30.9 K to 28.1 K (-9.05 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Sell | S | 298.28 | 3,777 | 1,126,604 | 30,936 | 34.7 K to 30.9 K (-10.88 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Payment of Exercise | F | 294.75 | 25,531 | 7,525,262 | 34,713 | 60.2 K to 34.7 K (-42.38 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Payment of Exercise | F | 294.75 | 2,992 | 881,892 | 60,244 | 63.2 K to 60.2 K (-4.73 %) |
| Sep 19 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Buy | M | 16.80 | 52,500 | 882,000 | 63,236 | 10.7 K to 63.2 K (+489.01 %) |
| May 08 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 16.80 | 29,048 | 488,006 | 52,500 | |
| May 08 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 16.80 | 3,902 | 65,554 | 0 | |
| May 08 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 262.15 | 2,037 | 534,000 | 10,736 | 12.8 K to 10.7 K (-15.95 %) |
| May 08 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 261.56 | 10,988 | 2,874,021 | 12,773 | 23.8 K to 12.8 K (-46.24 %) |
| May 08 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 260.88 | 700 | 182,616 | 23,761 | 24.5 K to 23.8 K (-2.86 %) |
| May 08 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 260.44 | 13,450 | 3,502,918 | 24,461 | 37.9 K to 24.5 K (-35.48 %) |
| May 08 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 260.44 | 1,873 | 487,804 | 37,911 | 39.8 K to 37.9 K (-4.71 %) |
| May 08 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 16.80 | 29,048 | 488,006 | 39,784 | 10.7 K to 39.8 K (+270.57 %) |
| May 08 2013 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 16.80 | 3,902 | 65,554 | 10,736 | 6.8 K to 10.7 K (+57.10 %) |
| Dec 21 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Option Exercise | M | 16.80 | 2,050 | 34,440 | 3,902 | |
| Dec 21 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Buy | M | 16.80 | 2,050 | 34,440 | 6,834 | 4.8 K to 6.8 K (+42.85 %) |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Option Exercise | A | 179.13 | 75,000 | 13,434,750 | 75,000 | |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & Gen Mgr IOPS | Option Exercise | A | 21.25 | 52,500 | 1,115,625 | 82,795 | |
| Nov 16 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 157.44 | 4,384 | 690,217 | 4,784 | 9.2 K to 4.8 K (-47.82 %) |
| Nov 16 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 156.94 | 400 | 62,776 | 9,168 | 9.6 K to 9.2 K (-4.18 %) |
| Nov 16 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 156.17 | 2,000 | 312,340 | 9,568 | 11.6 K to 9.6 K (-17.29 %) |
| Nov 16 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 155.18 | 6,900 | 1,070,742 | 11,568 | 18.5 K to 11.6 K (-37.36 %) |
| Nov 16 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 154.77 | 4,400 | 680,988 | 18,468 | 22.9 K to 18.5 K (-19.24 %) |
| Nov 16 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 153.48 | 657 | 100,836 | 22,868 | 23.5 K to 22.9 K (-2.79 %) |
| Oct 26 2012 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.92 | 30,000 | 657,600 | 0 |